Journal of Medicinal Chemistry · 2003 · 72 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAngiogenesisAngiogenesis In CancerLead Compound DesignEndothelial Proliferation
The identification of agents with specific antiproliferative or cytostatic activity against endothelial cells has significant value for the treatment of pathologies associated with angiogenesis, including solid tumors. Here, we describe a novel substituted dibenzo[b,d]pyran-6-one scaffold, exemplified by structures 9a and 10, and report preliminary in vitro activity data indicating that this scaffold is a promising lead for the development of specific inhibitors of endothelial cell proliferation.
18
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
Induction of angiogenesis during the transition from hyperplasia to neoplasia
J Folkman, Karol Watson, Donald E. Ingber et al. · Nature · 1989 · 1.9K citations
Medicine, Cell Biology, Oncology +10
A chemical switch for inhibitor-sensitive alleles of any protein kinase
Anthony C. Bishop, Jeffrey A. Ubersax, Dejah T. Petsch et al. · Nature · 2000 · 1.1K citations
Facial shape and judgements of female attractiveness
David I. Perrett, Keith A. May, Sakiko Yoshikawa · Nature · 1994 · 855 citations